Blog: Cancer
- New Study On Psa Test Screening For Prostate Cancer Raises More Questions
March 22, 2017
Read MoreNew Study on PSA Test Screening for Prostate Cancer Raises More Questions The results of a new cancer study raise important questions for men concerned with prostate cancer. The study found that older men (ages 55 to 74) with low PSA baseline levels did not benefit from aggressive early detection screening tests. According to the […]
- New Study Says Certain Type Of Sugar May Promote Cancer Growth
March 22, 2017
Read MoreNew Study Says Certain Type of Sugar May Promote Cancer Growth UCLA scientists have found that cancer reacts differently to different kinds of sugars. The cancer tumors metabolized fructose more easily than glucose. These findings are surprising given the commonly held belief that all sugars are the same when it comes to cancer cell growth. […]
- Drug Extends Survival In Patients With Metastatic Thyroid Cancer
March 22, 2017
Read MoreDrug Extends Survival in Patients with Metastatic Thyroid Cancer Interim results of a placebo-controlled, phase 3 study showed that patients suffering from metastatic thyroid cancer had longer progression-free survival when treated with the drug known as Sorafenib. The study encompassed about 420 patients with refractory differentiated thyroid cancer that had progressed in the past 14 months. […]
- New Class Of Cancer Drug Treatments Shrink Tumors But Will The Treatment Be Too Expensive
March 22, 2017
Read MoreNew class of cancer drug treatments shrink tumors, but will the treatment be too expensive? “Immunotherapies” — An exciting class of new cancer drugs may increase survival, but their use may be limited by their cost. These drugs are a type of immune system boosters that some believe will become the main treatment for more […]
- Intermittent Versus Continuous Androgen Deprivation In Prostate Cancer
March 22, 2017
Read MoreIntermittent versus Continuous Androgen Deprivation in Prostate Cancer In a randomized trial, researchers assigned some 1500 patients with newly diagnosed hormone-sensitive, metastatic disease either to continuous or intermittent androgen-deprivation therapy. By a median follow-up of almost 10 years, the hazard ratio for death with intermittent therapy was 1.10, but it was not statistically significant. Quality-of-life […]
- Diabetes Drug Warning Study Links Two Drugs To Cancer
March 22, 2017
Read MoreDiabetes Drug Warning — Study Links Two Drugs to Cancer The New York Times recently highlighted the work of Peter C. Butler, a UCLA endocrinologist who found precancerous changes in the pancreatic tissue of people who’d taken the antidiabetes drugs Januvia (sitagliptin) or Byetta (exenatide). The NIH will hold a meeting in June 2013 to […]
- University Of Oklahoma Scientists Discover Way To Stop Pancreatic Cancer In Early Stages
March 22, 2017
Read MoreUniversity Of Oklahoma Scientists Discover Way To Stop Pancreatic Cancer In Early Stages Researchers were able to show for the first time that a drug used in current chemotherapy for later stages of pancreatic cancer had a dramatic effect if used earlier.With low doses of Gefitinib, which has no known side effects at this level, […]
- Rectal Cancer Rates Rising For People Under 40 Better Screening Recommended
March 22, 2017
Read MoreRectal Cancer Rates Rising for People Under 40 — Better Screening Recommended While colon cancer rates have remained essentially the same in people under age 40 years, rectal cancer rates have been increasing by almost 4% every year since 1984. Because rectal cancer was relatively rare among this under-40 age group, physicians may fail to […]
- New Drug Treats Metastatic Skin Cancer
March 22, 2017
Read MoreNew Drug Treats Metastatic Skin Cancer Early-stage skin cancer (melanoma) that is confined to a spot on the skin can be surgically removed and in most cases stopped. But if cancer spreads, to other parts of the skin or to internal organs, melanoma is deadly. Chemotherapy drugs benefit fewer than 20 percent of such patients. […]